Catalyst Pharmaceuticals, Inc. (CPRX): Price and Financial Metrics
Catalyst Pharmaceuticals, Inc. (CPRX)
Today's Latest Price: $3.48 USD
Updated Nov 24 6:55pm
Add CPRX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
CPRX Stock Summary
- CPRX's current price/earnings ratio is 4.99, which is higher than only 4.49% of US stocks with positive earnings.
- The ratio of debt to operating expenses for Catalyst Pharmaceuticals Inc is higher than it is for about just 0.51% of US stocks.
- With a year-over-year growth in debt of -100%, Catalyst Pharmaceuticals Inc's debt growth rate surpasses just 0% of about US stocks.
- Stocks that are quantitatively similar to CPRX, based on their financial statements, market capitalization, and price volatility, are NTGR, IRBT, QDEL, YY, and FORM.
- Visit CPRX's SEC page to see the company's official filings. To visit the company's web site, go to www.catalystpharma.com.
CPRX Stock Price Chart Interactive Chart >
CPRX Price/Volume Stats
| Current price | $3.48 | 52-week high | $5.28 |
| Prev. close | $3.44 | 52-week low | $2.55 |
| Day low | $3.39 | Volume | 2,004,700 |
| Day high | $3.54 | Avg. volume | 1,898,306 |
| 50-day MA | $3.23 | Dividend yield | N/A |
| 200-day MA | $3.97 | Market Cap | 360.70M |
Catalyst Pharmaceuticals, Inc. (CPRX) Company Bio
Catalyst Pharmaceuticals focuses on the development and commercialization of prescription drugs targeting rare neurological diseases and disorders. The company was founded in 2002 and is based in Coral Gables, Florida.
Loading social stream, please wait...